More efficient early-stage studies, advanced genetic screening and the need for better drugs have helped a few cancer treatments obtain faster approval in the past two years. "We hope to be able to shave years off the time it takes to get final approval and save hundreds of millions of dollars per drug," the New York University Cancer Institute's Robert Schneider said.

Full Story:

Related Summaries